The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)
Abstract
Purpose. —To develop a guideline to improve the accuracy of immunohistochemical (IHC) estrogen receptor (ER) and progesterone receptor (PgR) testing in breast cancer and the utility of these receptors as predictive markers. Methods. —The American Society of Clinical Oncology and the College of American Pathologists convened an international Expert Panel that conducted a systematic review and evaluation of the literature in partnership with Cancer Care Ontario and developed recommendations for optimal IHC ER/PgR testing performance. Results. —Up to 20% of current IHC determinations of ER and PgR testing worldwide may be inaccurate (false negative or false positive). Most of the issues with testing have occurred because of variation in pre-analytic variables, thresholds for positivity, and interpretation criteria. Recommendations. —The Panel recommends that ER and PgR status be determined on all invasive breast cancers and breast cancer recurrences. A testing algorithm that relies on accurate, reproducible assay performance is proposed. Elements to reliably reduce assay variation are specified. It is recommended that ER and PgR assays be considered positive if there are at least 1% positive tumor nuclei in the sample on testing in the presence of expected reactivity of internal (normal epithelial elements) and external controls. The absence of benefit from endocrine therapy for women with ER-negative invasive breast cancers has been confirmed in large overviews of randomized clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Self-citationWolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2775 · Cited by 4,434
Self-citationHarris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,217
Self-citationHarvey, J. M., Clark, G. M., Osborne, C. K., & Allred, D. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1474 · Cited by 2,056
Self-citationWolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-18-asocco · Cited by 1,816
Self-citationBjörnström, L., & Sjöberg, M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0486 · Cited by 1,362
Beatson, G. (1896) · The Lancet · doi:10.1016/s0140-6736(01)72307-0 · Cited by 1,282
Winer, E. P., Hudis, C., Burstein, H. J., Wolff, A. C., Pritchard, K. I., Ingle, J. N., Chlebowski, R. T., Gelber, R., Edge, S. B., Gralow, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.121 · Cited by 1,031
Self-citationMcCarty, K. S., MILLER, L. S., Cox, E. B., Konrath, J. G., & McCarty, K. S. (1985) · PubMed · Cited by 1,027
Prognostic Factors in Breast Cancer: College of American Pathologists Consensus Statement 1999
Fitzgibbons, P. L., Page, D. L., Weaver, D., Thor, A. D., Allred, D. C., Clark, G. M., Ruby, S. G., O'Malley, F., Simpson, J. F., Connolly, J. L., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0966-pfibc · Cited by 1,016
Self-citationThe value of estrogen and progesterone receptors in the treatment of breast cancer
Osborne, C. K., Yochmowitz, M. G., Knight, W. A., & McGuire, W. L. (1980) · Cancer · doi:10.1002/1097-0142(19801215)46:12+<2884::aid-cncr2820461429>3.0.co;2-u · Cited by 720
Self-citationEstrogen Receptors in Human Breast Cancer
McGuire, W. L. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107175 · Cited by 668
Ellis, M. J., Tao, Y., Luo, J., A'Hern, R., Evans, D. B., Bhatnagar, A. S., Chaudri Ross, H. A., von Kameke, A., Miller, W. R., Smith, I., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn309 · Cited by 653
Self-citationEstrogen Receptors in Human Breast Cancer
Powles, T. (1976) · Journal of Clinical Pathology · doi:10.1136/jcp.29.5.467-d · Cited by 614
Taylor, C. R., & Levenson, R. M. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02513.x · Cited by 609
Predicting Response to Endocrine Therapy in Human Breast Cancer: A Hypothesis
Horowitz, K. B., McGuire, W. L., Pearson, O. H., & Segaloff, A. (1975) · Science · doi:10.1126/science.168640 · Cited by 569
Massarweh, S., Osborne, C. K., Creighton, C. J., Qin, L., Tsimelzon, A., Huang, S., Weiss, H., Rimawi, M., & Schiff, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2707 · Cited by 488
Self-citationViale, G., Regan, M. M., Maiorano, E., Mastropasqua, M. G., Dell'Orto, P., Rasmussen, B. B., Raffoul, J., Neven, P., Orosz, Z., Braye, S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.9453 · Cited by 452
Self-citationDowsett, M., Allred, C., Knox, J., Quinn, E., Salter, J., Wale, C., Cuzick, J., Houghton, J., Williams, N., Mallon, E., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.9437 · Cited by 450
Self-citationMcCarty, K. S., Szabo, E. M., Flowers, J. L., Cox, E. B., Leight, G. S., Miller, L. A., Konrath, J. G., Jt, S., Budwit, D. A., & Wt, C. (1986) · PubMed · Cited by 417
Progesterone Receptors as a Prognostic Factor in Stage II Breast Cancer
Clark, G. M., McGuire, W. L., Hubay, C. A., Pearson, O. H., & Marshall, J. S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312013092240 · Cited by 366
Rhodes, A., Jasani, B., Barnes, D. M., Bobrow, L. G., & Miller, K. D. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.2.125 · Cited by 325
Self-citationElledge, R. M., Green, S., Pugh, R., Allred, D. C., Clark, G. M., Hill, J., Ravdin, P., Martino, S., & Osborne, C. K. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000320)89:2<111::aid-ijc2>3.0.co;2-w · Cited by 325
Self-citationInfluence of Synthetic Oestrogens on Advanced Malignant Disease
Haddow, A., Watkinson, J., Paterson, E., & KOLLER, P. C. (1944) · BMJ · doi:10.1136/bmj.2.4368.393 · Cited by 299
Mohsin, S. K., Weiss, H., Havighurst, T., Clark, G. M., Berardo, M., Roanh, L. D., To, T. V., Zho, Q., Love, R. R., & Allred, D. C. (2004) · Modern Pathology · doi:10.1038/modpathol.3800229 · Cited by 290
Self-citationEllis, M. J., Gao, F., Dehdashti, F., Jeffe, D. B., Marcom, P. K., Carey, L. A., Dickler, M. N., Silverman, P., Fleming, G. F., Kommareddy, A., et al. (2009) · JAMA · doi:10.1001/jama.2009.1204 · Cited by 287
Treatment of Primary Breast Cancer with Chemotherapy and Tamoxifen
Fisher, B., Redmond, C., Brown, A., Wolmark, N., Wittliff, J., Fisher, E. R., Plotkin, D., Bowman, D., Sachs, S., Wolter, J., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107023050101 · Cited by 287
Self-citationVisvanathan, K., Chlebowski, R. T., Hurley, P., Col, N. F., Ropka, M., Collyar, D., Morrow, M., Runowicz, C., Pritchard, K. I., Hagerty, K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.5179 · Cited by 286
Self-citationMauri, D., Pavlidis, N., Polyzos, N. P., & Ioannidis, J. P. A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj357 · Cited by 286
Goldstein, M., Ferkowicz, M., Odish, H., Mani, M., & Hastah, M. (2003) · American Journal of Clinical Pathology · doi:10.1309/qphd-rb00-qxgm-uq9n · Cited by 280
Fisher, B., Redmond, C., Brown, A., Wickerham, D. L., Wolmark, N., Allegra, J., Escher, G., Lippman, M., Savlov, E., & Wittliff, J. (1983) · Journal of Clinical Oncology · doi:10.1200/jco.1983.1.4.227 · Cited by 260
Self-citationArpino, G., Green, S. J., Allred, D. C., Lew, D., Martino, S., Osborne, C. K., & Elledge, R. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0110 · Cited by 255
Self-citationBarnes, D., Harris, W., Smith, P., Millis, R., & Rubens, R. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.563 · Cited by 241
Badve, S. S., Baehner, F. L., Gray, R. P., Childs, B. H., Maddala, T., Liu, M.-L., Rowley, S. C., Shak, S., Perez, E. D., Shulman, L. J., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.6424 · Cited by 236
Self-citationCheang, M. C. U., Treaba, D. O., Speers, C. H., Olivotto, I. A., Bajdik, C. D., Chia, S. K., Goldstein, L. C., Gelmon, K. A., Huntsman, D., Gilks, C. B., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.4155 · Cited by 206
Expanding Priorities — Confronting Chronic Disease in Countries with Low Income
Anderson, G. F., & Chu, E. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068182 · Cited by 197
Stendahl, M., Rydén, L., Nordenskjöld, B. A., Jönsson, P., Landberg, G., & Jirström, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0248 · Cited by 174
Regan, M. M., Viale, G., Mastropasqua, M. G., Maiorano, E., Golouh, R., Carbone, A., Brown, B., Suurküla, M., Langman, G., Mazzucchelli, L., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj415 · Cited by 164
Self-citationRecommendations for Validating Estrogen and Progesterone Receptor Immunohistochemistry Assays
Fitzgibbons, P. L., Murphy, D. A., Hammond, M. E., Allred, D. C., & Valenstein, P. N. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/134.6.930 · Cited by 137
Self-citationLove, R. R., Duc, N. B., Allred, D. C., Binh, N. C., Định, N. V., Kha, N. N., Thuân, T. V., Mohsin, S. K., Roanh, L. D., Khang, H. X., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.169 · Cited by 132
Self-citationEstrogen Receptor Analysis for Breast Cancer
Diaz, L. K., & Sneige, N. (2005) · Advances in Anatomic Pathology · doi:10.1097/00125480-200501000-00003 · Cited by 127
Viale, G., Regan, M. M., Maiorano, E., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.6393 · Cited by 115
Self-citationEffect of Prolonged Formalin Fixation on the Immunohistochemical Reactivity of Breast Markers
Arber, D. A. (2002) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200206000-00015 · Cited by 108
Yamashita, H., Ando, Y., Nishio, M., et al. (2006) · Breast Cancer · doi:10.2325/jbcs.13.74 · Cited by 105
Phillips, T., Murray, G., Wakamiya, K., et al. (2007) · Applied immunohistochemistry & molecular morphology · doi:10.1097/01.pai.0000213135.16783.bc · Cited by 88
Ogawa, Y., Moriya, T., Kato, Y., Oguma, M., Ikeda, K., Takashima, T., Nakata, B., Ishikawa, T., & Hirakawa, K. (2004) · Breast Cancer · doi:10.1007/bf02984548 · Cited by 76
Treatment of Metastatic Breast Cancer
Gradishar, W. J. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0184 · Cited by 69
Nichols, H. B., Trentham‐Dietz, A., Love, R. R., Hampton, J. M., Anh, P. T. H., Allred, D. C., Mohsin, S. K., & Newcomb, P. A. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.41.14.1 · Cited by 68
Self-citationEstrogen-receptor interactions in target tissues.
Jensen, E. V., DeSombre, E. R., Hurst, D. J., et al. (1967) · PubMed · Cited by 67
Influence of Fixation, Antibody Clones, and Signal Amplification on Steroid Receptor Analysis
Wasielewski, R., Mengel, M., Nolte, M., & Werner, M. (1998) · The Breast Journal · doi:10.1046/j.1524-4741.1998.410033.x · Cited by 63
Historical perspective on hormonal therapy of advanced breast cancer
JORDAN, C. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85031-7 · Cited by 55
Thomson, C. S., Twelves, C. J., Mallon, E., et al. (2002) · The Breast · doi:10.1054/brst.2002.0451 · Cited by 49
A simple index using video image analysis to predict disease outcome in primary breast cancer
Lockwood, C. A., Ricciardelli, C., Raymond, W. A., Seshadri, R., McCaul, K. A., & Horsfall, D. J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990621)84:3<203::aid-ijc1>3.0.co;2-u · Cited by 32
Murray, J., Young, O. E., Renshaw, L., White, S. L., Williams, L. J., Evans, D. B., Thomas, J., Dowsett, M., & Dixon, J. M. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0027-0 · Cited by 28
Self-citationMalley, B. O. (2002) · Wiley eBooks · doi:10.1002/0471203076.emm0526 · Cited by 13
An assessment of current achievements in the systemic management of breast cancer
Lippman, M. E. (1984) · Breast Cancer Research and Treatment · doi:10.1007/bf01806388 · Cited by 9
Cited by
Breast cancer statistics, 2013
DeSantis, C., Ma, J., Bryan, L., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21203 · Cited by 2,143
Dowsett, M., Nielsen, T. O., A'Hern, R., Bartlett, J., Coombes, R. C., Cuzick, J., Ellis, M., Henry, N. L., Hugh, J. C., Lively, T., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr393 · Cited by 1,977
Self-citationEstrogen and progesterone receptor testing in breast cancer: ASCO/CAP Guideline update
Allison, K. H., Hammond, M. E. H., Dowsett, M., McKernin, S. E., Carey, L. A., Fitzgibbons, P. L., Hayes, D. F., Lakhani, S. R., Chavez-MacGregor, M., Perlmutter, J., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02309 · Cited by 1,574
Self-citationUS Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
Howlader, N., Altekruse, S. F., Li, C. I., Chen, V. W., Clarke, C. A., Ries, L. A. G., & Cronin, K. A. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju055 · Cited by 1,508
Awareness and current knowledge of breast cancer
Akram, M., Iqbal, M., Daniyal, M., & Khan, A. U. (2017) · Biological Research · doi:10.1186/s40659-017-0140-9 · Cited by 1,406
Metadata
- Authors
- Hammond, M. E. H., Hayes, D. F., Dowsett, M., Allred, D. C., Hagerty, K. L., Badve, S., Fitzgibbons, P. L., Francis, G., Goldstein, N. S., Hayes, M., Hicks, D. G., Lester, S., Love, R., Mangu, P. B., McShane, L., Miller, K., Osborne, C. K., Paik, S., Perlmutter, J., Rhodes, A., Sasano, H., Schwartz, J. N., Sweep, F. C. G., Taube, S., Torlakovic, E. E., Valenstein, P., Viale, G., Visscher, D., Wheeler, T., Williams, R. B., Wittliff, J. L., & Wolff, A. C.
- Venue
- Archives of Pathology & Laboratory Medicine
- Published
- 2010-07
- Volume
- 134
- Issue
- 7
- Pages
- e48-e72
- ISSN
- 0003-9985 (ISSN-L)
- 1543-2165
- OpenAlex
- W4234081105
- Cited by
- 1,042
- References
- 58
- FWCI
- 11.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.